Cargando…

Advanced small cell carcinoma of the bladder: clinical characteristics, treatment patterns and outcomes in 960 patients and comparison with urothelial carcinoma

To describe the clinical characteristics, treatment patterns and outcomes in advanced small cell bladder cancer (aSCBC) patients and compare to those with urothelial carcinoma (UC). Individuals in the National Cancer Data Base with a diagnosis of either nodal (TxN+M0) or distant metastatic (TxNxM1)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Geynisman, Daniel M., Handorf, Elizabeth, Wong, Yu‐Ning, Doyle, Jamie, Plimack, Elizabeth R., Horwitz, Eric M., Canter, Daniel J., Uzzo, Robert G., Kutikov, Alexander, Smaldone, Marc C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2015
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735777/ https://www.ncbi.nlm.nih.gov/pubmed/26679712 http://dx.doi.org/10.1002/cam4.577

Ejemplares similares

Comparative Effectiveness of Front-Line Ipilimumab and Nivolumab or Axitinib and Pembrolizumab in Metastatic Clear Cell Renal Cell Carcinoma
por: Zarrabi, Kevin K, et al.
Publicado: (2022)

What can the National Cancer Database tell us about disparities in advanced bladder cancer outcomes?
por: Joshi, Shreyas S., et al.
Publicado: (2018)

Role of immunotherapy in localized muscle invasive urothelial cancer
por: Kaur, Jasmeet, et al.
Publicado: (2021)

Between the Hammer and Anvil: Resolution of unresectable muscle invasive bladder cancer in a renal transplant patient after cessation of immunosuppressive therapy
por: Strauss, David, et al.
Publicado: (2023)

FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder
por: Guancial, Elizabeth A, et al.
Publicado: (2014)

Approved checkpoint inhibitors in bladder cancer: which drug should be used when?
por: Ghatalia, Pooja, et al.
Publicado: (2018)

The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder
por: van Doeveren, Thomas, et al.
Publicado: (2020)

Resolution of a Debilitating Paraneoplastic Parkinson-like Neurological Syndrome Following Tyrosine Inhibitor Therapy and Consolidative Nephrectomy in a Patient with Advanced Clear Cell Renal Cell Carcinoma
por: Ali, Naveed, et al.
Publicado: (2017)

Comparative Genomic Landscape of Urothelial Carcinoma of the Bladder Among Patients of East and South Asian Genomic Ancestry
por: Peak, Taylor, et al.
Publicado: (2023)

HER2 as a target in invasive urothelial carcinoma
por: Bellmunt, Joaquim, et al.
Publicado: (2015)

The Evolution of Clinical Trials in Renal Cell Carcinoma: A Status Report for 2013–2016 from the ClinicalTrials.gov Website
por: Ghatalia, Pooja, et al.
Publicado: (2017)

Human Gut Mycobiome and Fungal Community Interaction: The Unknown Musketeer in the Chemotherapy Response Status in Bladder Cancer
por: Bukavina, Laura, et al.
Publicado: (2022)

Multiple brain metastases in a patient with ypT0N0 micropapillary urothelial carcinoma of the bladder
por: Kuppa, Srikar, et al.
Publicado: (2021)

Downregulation of miR‐133b predict progression and poor prognosis in patients with urothelial carcinoma of bladder
por: Chen, Xiaonan, et al.
Publicado: (2016)

Intravesical therapy for urothelial carcinoma of the bladder
por: Manoharan, M.
Publicado: (2011)

Risk factors for upper tract urothelial recurrence following local excision of bladder cancer
por: Lin, Ning, et al.
Publicado: (2018)

Prognostic values of the clinicopathological characteristics and survival outcomes in micropapillary urothelial carcinoma of the bladder: A SEER database analysis
por: Jin, Di, et al.
Publicado: (2020)

Cutaneous metastasis of bladder urothelial carcinoma
por: Hasan, Osamah, et al.
Publicado: (2019)

Bladder Recurrence Following Upper Tract Surgery for Urothelial Carcinoma: A Contemporary Review of Risk Factors and Management Strategies
por: Mertens, Laura S., et al.
Publicado: (2023)

Detection of HPV infection in urothelial carcinoma using RNAscope: Clinicopathological characterization
por: Musangile, Fidele Y., et al.
Publicado: (2021)

Integrated proteogenomic characterization of urothelial carcinoma of the bladder
por: Xu, Ning, et al.
Publicado: (2022)

Role of angiogenesis in urothelial bladder carcinoma
por: Fus, Łukasz Piotr, et al.
Publicado: (2016)

Bladder melanosis with concurrent urothelial carcinoma
por: Yau, Susanna E., et al.
Publicado: (2017)

Giant Cell Urothelial Carcinoma of Bladder
por: Wijesinghe, Harshima Disvini, et al.
Publicado: (2021)

Molecular classification of urothelial bladder carcinoma
por: Schwarzova, Lucia, et al.
Publicado: (2023)

Copy number alterations in urothelial carcinomas: their clinicopathological significance and correlation with DNA methylation alterations
por: Nishiyama, Naotaka, et al.
Publicado: (2011)

Autocrine signaling by receptor tyrosine kinases in urothelial carcinoma of the bladder
por: Lee, Young H., et al.
Publicado: (2021)

Nested variant of urothelial carcinoma of the urinary bladder
por: Terada, Tadashi
Publicado: (2011)

CD10 expression in urothelial carcinoma of the bladder
por: Bahadir, Burak, et al.
Publicado: (2009)

Comprehensive molecular characterization of urothelial bladder carcinoma
Publicado: (2014)

Protein Profiling of Bladder Urothelial Cell Carcinoma
por: Hu, Jinghai, et al.
Publicado: (2016)

The use of intravesical BCG in urothelial carcinoma of the bladder
por: Alhunaidi, Omar, et al.
Publicado: (2019)

Advances in the Management of Patients With Urothelial Carcinomas of the Bladder
por: Shah, Amishi, et al.
Publicado: (2018)

Autophagy and urothelial carcinoma of the bladder: A review
por: Chandrasekar, Thenappan, et al.
Publicado: (2016)

Testicular metastasis from urothelial carcinoma of the bladder
por: Fukagawa, Eri, et al.
Publicado: (2021)

Venous thromboembolism in metastatic urothelial carcinoma or variant histologies: incidence, associative factors, and effect on survival
por: Ramos, Jorge D., et al.
Publicado: (2016)

Development and validation of a nomogram to predict the prognosis of patients with squamous cell carcinoma of the bladder
por: Hu, Mei-Di, et al.
Publicado: (2019)

Xpert® bladder cancer detection as a diagnostic tool in upper urinary tract urothelial carcinoma: preliminary results
por: D’Elia, Carolina, et al.
Publicado: (2022)

Enfortumab Vedotin in Metastatic Urothelial Carcinoma: Survival and Safety in a European Multicenter Real-world Patient Cohort
por: Zschäbitz, Stefanie, et al.
Publicado: (2023)

Identification of key pathways and genes influencing prognosis in bladder urothelial carcinoma
por: Ning, Xin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2euo0ojpum513nlnin8s7hvb1k